🇺🇸 FDA
Patent

US 8168202

Hexavalent bovine rotavirus reassortant composition designed for use in developing countries

granted A61KA61K2039/70A61K39/12

Quick answer

US patent 8168202 (Hexavalent bovine rotavirus reassortant composition designed for use in developing countries) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K2039/70, A61K39/12, A61K39/15, A61P